Bioceres Crop Solutions (NASDAQ:BIOX) Downgraded by Wall Street Zen to Sell

Bioceres Crop Solutions (NASDAQ:BIOX) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

A number of other brokerages have also issued reports on BIOX. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Friday, March 27th. Canaccord Genuity Group cut their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a research note on Friday, January 2nd. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $4.00.

Bioceres Crop Solutions Stock Performance

Shares of Bioceres Crop Solutions stock opened at $0.54 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.69 and a current ratio of 0.90. The firm has a 50-day moving average of $0.58 and a 200-day moving average of $1.21. Bioceres Crop Solutions has a 52-week low of $0.35 and a 52-week high of $5.18. The stock has a market cap of $34.16 million, a PE ratio of -0.15 and a beta of 0.53.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Friday, March 13th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of $0.07 by ($0.15). Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%. The business had revenue of $73.67 million during the quarter, compared to analyst estimates of $104.55 million. As a group, sell-side analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several institutional investors and hedge funds have recently bought and sold shares of the company. Ardsley Advisory Partners LP grew its stake in Bioceres Crop Solutions by 4.7% during the second quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock worth $4,441,000 after buying an additional 45,000 shares in the last quarter. Ballast Asset Management LP raised its position in shares of Bioceres Crop Solutions by 69.9% in the 3rd quarter. Ballast Asset Management LP now owns 745,030 shares of the company’s stock valued at $1,048,000 after buying an additional 306,624 shares in the last quarter. Marshall Wace LLP raised its position in shares of Bioceres Crop Solutions by 180.0% in the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after buying an additional 382,744 shares in the last quarter. GAM Holding AG bought a new stake in shares of Bioceres Crop Solutions during the 4th quarter worth approximately $655,000. Finally, Susquehanna International Group LLP bought a new stake in shares of Bioceres Crop Solutions during the 3rd quarter worth approximately $315,000. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.